Home › Targets › beta-sarcoglycan

beta-sarcoglycan (1 companies · 2 programs)

Companies with an active program directed at beta-sarcoglycan.

Sarepta Therapeutics, Inc. SRPT

bidridistrogene xeboparvovec — Limb-Girdle Muscular Dystrophy Phase 3
SRP-9004 — Limb-Girdle Muscular Dystrophy Phase 1